Exchange: NASDAQ·Updated 07:57 PM EDT
BCTX logo

BCTXBriaCell Therapeutics Corp

$3.26
$0.21
(6.05%)
Today
Closed $3.26
$0.1356
(4.16%)
After Hours
Reported EarningsJun 10
Mkt Cap$28.36M
Vol217,589.00

About

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
17

Frequently Asked Questions

What is Market Cap of BriaCell Therapeutics Corp - Ordinary Shares - New?
What is the 52-week high for BriaCell Therapeutics Corp - Ordinary Shares - New?
What is the 52-week low for BriaCell Therapeutics Corp - Ordinary Shares - New?
What is BriaCell Therapeutics Corp - Ordinary Shares - New stock price today?
What was BriaCell Therapeutics Corp - Ordinary Shares - New stock price yesterday?
What is the PE ratio of BriaCell Therapeutics Corp - Ordinary Shares - New?
What is the Price-to-Book ratio of BriaCell Therapeutics Corp - Ordinary Shares - New?
What is the 50-day moving average of BriaCell Therapeutics Corp - Ordinary Shares - New?
How many employees does BriaCell Therapeutics Corp - Ordinary Shares - New have?

Advertisement|Remove ads.